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Background: We assessed the effectiveness of applying the distance from the orifice of the
bronchus to visualized peripheral pulmonary lesion (PPL) under endobronchial ultrasono-
graphy (EBUS) to transbronchial biopsy (TBB), as an alternative to EBUS with a guide sheath
(GS) and fluoroscopy.
Patients and methods: From October 2004 to July 2005, a total of 158 consecutive
patients with solitary PPLs, which were not visualized under flexible video bronchoscopy,
were received EBUS for advanced localization subsequently. One hundred and thirteen of
158 patients with solitary PPLs which were visualized on EBUS image were included in this
prospective study and randomly divided into two groups for TBB using different methods.
In group EBUS-D (57 patients) the distance from the bronchial orifice to pulmonary lesion
was measured, then the biopsy forceps were advanced to this measured distance and
biopsy followed. In group EBUS (56 patients) the biopsy forceps were advanced regardless
of distance. The diagnostic yields were then compared.
Results: TBBs in group EBUS-D patients had a significantly higher diagnostic yield (45/57,
78.9%) than group EBUS patients (32/56, 57.1%) [P ¼ 0:013]. Size and location of lesion,
duration of EBUS, diagnosis of malignancy, and whether the probe was located within the
lesion on EBUS image did not differ between these two groups. Mild bleeding occurred in
three patients in group EBUS-D and two in group EBUS. One group EBUS patient had a self-
limited pneumothorax.
Conclusions: Measuring and applying the distance between the orifice of bronchus and the
lesion could increase the diagnostic yield of EBUS-guided TBBs for PPLs.
& 2006 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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EBUS for peripheral pulmonary lesions 739Introduction The study was approved by the institutional review board,Endobronchial ultrasonography (EBUS), first introduced in
1990 by Hurter and Hanrath, has been evaluated in several
clinical studies and shown to provide information about the
location and size of pulmonary lesions.1–3 The recently
developed small-caliber ultrasonographic probe can be
successfully introduced into the working channel of a
flexible video bronchoscope to localize peripheral pulmon-
ary lesions (PPLs) prior to diagnostic techniques including
transbronchial biopsy (TBB).4 However, once the location of
the lesion is identified precisely by EBUS, the probe is
withdrawn to enable biopsy forceps to be introduced into
the working channel. This practice is subject to error in that
unguided biopsy forceps may enter other bronchial branches
than the original EBUS-identified one, thus producing
erroneous TBBs results.
In order to overcome this disadvantage, the technique of
EBUS with a guide sheath (GS) has been developed to
diagnose PPLs.5–7 After the probe is withdrawn, leaving the
GS in place, the biopsy forceps are introduced into the
sheath for biopsy. Therefore, diagnostic yield can be
increased by ensuring that TBBs are performed at the
correct location as identified by the EBUS. Nevertheless,
fluoroscopy is still used to confirm whether the forceps
reach the lesion so as to diminish the probability of
advancing the forceps an inappropriate distance. This
approach is time consuming and costly, exposes both
personnel and patients to radiation, and requires several
safety procedures to avoid radiation effects.8,9 To assess the
three-dimensional location of the lesion from at least two
planes is necessary, which requires a change in the patient’s
position, possibly increasing patient discomfort.
The present study was undertaken in order to examine
the usefulness of a simple technique, applying the measured
distance between bronchial orifice and the lesion to EBUS-
guided TBBs for diagnosis of PPLs. The goal is to determine
whether or not there exists an acceptable adaptation which,
in the absence of GS and fluoroscopy equipment, increases
diagnostic yield and is free of the drawbacks incurred by
fluoroscopy. Factors which influence the diagnostic yield of
EBUS-guided TBB were also investigated.Materials and methods
Patients
Between October 1, 2004 and July 31, 2005 at the
bronchoscopy unit of Chang Gung Memorial Hospital (Kaoh-
siung, Taiwan), a total of 1178 patients received broncho-
scopic examinations for various indications. There were 247
consecutive patients with solitary pulmonary lesions on
chest roentgenogram referred for diagnostic bronchoscopy.
One hundred and fifty-eight of 247 patients whose pulmon-
ary lesions could not be detected under flexible video
bronchoscopy were received EBUS for advanced localization
subsequently. One hundred and thirteen of 158 patients
whose lesions were visualized on EBUS images were included
in this study and randomly divided into two groups (group
EBUS-D and group EBUS) for TBBs using different methods.and informed consent was obtained from the patients.
Radiography
Chest roentgenogram and computerized tomography (CT)
were used to determine the size and location of these
lesions. CT imaging with a contrast medium (total volume,
100mL at 1mL/s) was performed using a multislice CT
(Somatom Volume Zoom, Simens, Erlangen, Germany) with
5-mm slices. Images were reconstructed at 1mm. The chest
CT was reviewed by two independent radiologists, who
measured the size of lesions and determined their location
in relation to the segmental bronchus. The greatest
diameter was defined as the size of the lesion. In order to
analyze the importance of lesion size in the diagnostic yield,
we stratified the patients into three subsets: lesion 43 cm,
lesion 42 cm but p3 cm, and lesion p2 cm in diameter.
Flexible video bronchoscopy
A flexible video bronchoscopy unit (P260F, Olympus, Tokyo,
Japan) equipped with a high-definition monitor (OEV181H,
Olympus, Tokyo, Japan) was used for all procedures in this
study. Local anesthesia of the upper respiratory tract was
achieved using 2% lidocaine. Continuous pulse oximetry was
performed during bronchoscopy, and blood pressure was
measured every 5min. Oxygen was administered by a nasal
cannula, and the flow was adjusted upward from 2L/min to
maintain the pulse oximetric saturation 490%. After the
bronchoscope was advanced beyond the vocal cords, all
segments of the bronchial tree were visualized. A lesion was
defined as peripheral when it was beyond the segmental
bronchus and not visible by bronchoscopy (no evidence of
endobronchial lesion, extrinsic compression, submucosal tu-
mor, or narrowing, inflammation or bleeding of the bronchus).
Bronchoscopic procedures were performed by five well-trained
bronchoscopists who all had more than 10 years of experience.
The average number of bronchoscopic procedures performed
per year by each bronchoscopist was 200 or greater.
EBUS
EBUS was performed using an endoscopic ultrasound system
(EU-M30S, Olympus, Tokyo, Japan), equipped with a 20-MHz
mechanical radial type miniature probe (UM-S20-20R,
Olympus, Tokyo, Japan) with an outer diameter of 1.7mm.
Based on the radiographic findings, the probe was nego-
tiated into the bronchus of interest. The probe was
advanced until it reached a point where the bronchoscopist
sensed resistance, and then pulled back for scanning. When
an EBUS image of the lesion could be obtained, the probe
location was described and divided into two types: the
probe was located within the lesion, and the probe was
located adjacent to it (Fig. 1).
In group EBUS-D patients, once the location of the lesion
was identified precisely by EBUS, the probe was marked by a
colored tape against the orifice of the working channel of
the flexible video bronchoscope (Fig. 2). Then, switching the
image from ultrasonographic to bronchoscopic on the
monitor, the probe was pulled out slowly while the patient
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Figure 1 Probe location on EBUS image. Left, the probe (arrow) was located within the lesion. Right, the probe (arrow) was located
adjacent to it.
Figure 2 Once the location of the lesion was identified precisely by EBUS, the probe was marked by a colored tape against the
orifice of the working channel of the flexible video bronchoscope.
Y.-H. Chung et al.740held his or her breath at the point of forced inspiration.
When the transducer (which was positioned behind) of the
probe reached the orifice of the subsegmental bronchus, the
distance between colored tape on the probe and the orifice
of working channel was measured by an assistant (Fig. 3).
The total duration of EBUS was defined as the time from the
insertion of the probe to withdrawal of the probe.TBBs
A biopsy forceps (FB-19C-1 or FB-15C-1, Olympus, Tokyo,
Japan) was introduced into the working channel of theflexible video bronchoscope for obtaining specimens in this
study.
In patients in group EBUS, TBBs were performed regard-
less of distance. The cups of the forceps were closed
initially, and the forceps was introduced into the corre-
sponding bronchus previously localized with EBUS. The
biopsy forceps was advanced distally until the bronchosco-
pist sensed resistance, retracted 0.5–1 cm, opened, and
then advanced slowly until resistance was encountered.
Again the forceps were closed and retracted.
In patients in group EBUS-D, TBBs were performed after
the distance was identified by EBUS. When the cups of the
forceps reached the orifice of the subsegmental bronchus,
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Figure 3 When the transducer (arrow) of the probe reached the orifice of the subsegmental bronchus, the distance between
colored tape on the probe and the orifice of the working channel was measured by an assistant.
EBUS for peripheral pulmonary lesions 741the coil of the biopsy forceps was held by thumb and index
finger of the bronchoscopist at the outer edge of the orifice
of the working channel with the measured distance. Then,
the biopsy forceps was introduced into the target bronchial
branch and advanced till the fingers were 0.5–1 cm from the
orifice of the working channel while the patient held his or
her breath at the point of forced inspiration. At that time,
the cups were opened and advanced slowly until the fingers
were against the orifice of working channel. Again the
forceps were closed and retracted.
Three to five sufficient biopsy specimens were obtained in
all study patients and were immersed in 10% formalin and
analyzed by two study-blinded pathologists for definitive
histologic assessment. Patients in whom TBBs were not
diagnostic underwent percutaneous CT-guided needle as-
piration cytology or biopsy, or operation to obtain a final
diagnosis.Statistical analysis
Nominal variables, including gender, location of lesion,
number of specimens, complications, diagnosis of malig-
nancy, probe location, and diagnostic yield were expressed
as number and frequency (%). Parameters including age, size
of lesion, duration of EBUS, and measured distance were
expressed as mean7SD.
For categorical variables, comparisons between different
groups were made with the w2-test or Fisher’s exact test,
when appropriate. For continuous variables, comparisons
were made with Student’s t-test. Multivariate logistic
regression test using Statistical Package for the Social
Sciences (SPSS) software version 11.5 was used to further
confirm the results of analysis of independent variables forinfluencing diagnostic yield of EBUS-guided TBBs. Values of
Po0.05 were considered statistically significant.
Results
Patient characteristics
A total of 158 consecutive patients with solitary PPLs
received EBUS for advanced localization at our broncho-
scopy unit during a 10-month period. One hundred and
thirteen of 158 patients had lesions which could be
visualized on EBUS images. The localization rate of EBUS
was 71.5%. There were 75 men and 38 women, with an
average age of 59.4712.8 yr (20–79 yr). The mean diameter
of the PPLs was 24.578.2mm (10–44mm). Thirty lesions
(26.5%) were located in the right upper lobe, followed by
right lower lobe, left lower lobe, left upper lobe, right
middle lobe, and lingula with decreasing frequency. Probe
location was described as within the lesion on EBUS image in
86 patients (76.1%). Duration of EBUS was 177.9729.7 s
(65–273 s). There was brisk hemorrhage in five patients as a
result of forceps biopsy. Self-limited pneumothorax second-
ary to TBBs occurred in one patient, but did not necessitate
insertion of a chest tube. The characteristics of the patients
are summarized in Table 1.
Final diagnosis
Diagnosis was established from TBBs in 77 of 113 patients
(68.1%). The remaining 36 patients’ final diagnoses were
made by operation in 19 patients, and 12 patients under-
went percutaneous CT-guided aspiration cytology or biopsy.
One patient’s pulmonary lesion disappeared after antibiotic
treatment, and pneumonia was diagnosed clinically.
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Table 1 Characteristics of patients undergoing endo-
bronchial ultrasonography-guided transbronchial biopsy.
Characteristic Result/mean7SD (%)
Gender
Male 75 (66.4)
Female 38 (33.6)
Age (yr) 59.4712.8 (20–79)
Size of lesions (mm) 24.578.2 (10–44)
Location of lesions
Right upper lobe 30 (26.5)
Right middle lobe 15 (13.3)
Right lower lobe 27 (23.9)
Left upper lobe 17 (15.0)
Lingula 5 (4.4)
Left lower lobe 19 (16.8)
Location of the probe on EBUS
Within the lesion 86 (76.1)
Adjacent to the lesion 27 (23.9)
Duration of EBUS (s) 177.9729.7 (65–273)
Number of specimens
3 40 (35.4)
4 28 (24.8)
5 45 (39.8)
Diagnostic yield of TBB 77/113 (68.1)
Complications
Bleeding 5/113 (4.4)
Pneumothorax 1/113 (0.9)
Final diagnosis
Malignant 82/113 (72.6)
Benign 27/113 (23.9)
Lost to follow up 4/113 (3.5)
Table 2 Final diagnosis in 109 patients.
Diagnosis Number (%)
Malignant 82 (72.2)
Adenocarcinoma 46 (42.2)
Squamous cell carcinoma 10 (9.1)
Small cell carcinoma 4 (3.7)
Adenosquamous carcinoma 1 (0.9)
Bronchoalveolar carcinoma 5 (4.6)
Undifferentiated NSCLC 11 (10.1)
Primary melanoma 1 (0.9)
Metastasis 4 (3.7)
Benign 27 (24.9)
Tuberculosis 15 (13.8)
NTMy 1 (0.9)
Cryptococcosis 3 (2.8)
Aspergillosis 1 (0.9)
Sarcoidosis 2 (1.8)
Leiomyoma 1 (0.9)
Hamartoma 1 (0.9)
BOOPz 1 (0.9)
Pneumoconiosis 1 (0.9)
Pneumonia 1 (0.9)
Total 109 (100)
NSCLC—non-small-cell lung cancer.
yNTM—non-tuberculous mycobacterium.
zBOOP—bronchiolitis obliterans of organizing pneumonia.
Y.-H. Chung et al.742Four patients were lost to follow up. The final diagnosis was
made in a total of 109 patients, including 82 (72.2%)
malignancies and 27 (24.9%) benign diseases (Table 2).Comparison between EBUS-D and EBUS groups
The diagnostic yield of TBBs in group EBUS-D patients was
78.9% (45/57) which was significantly higher than in the
EBUS patients (57.1%) (P ¼ 0:013). Furthermore, gender,
age, size and location of lesion, probe location on EBUS
image, duration of EBUS, number of specimens, complica-
tions and diagnosis of malignancy were not different
between these two groups (Table 3). In the EBUS-D group,
the average of measured distance was 3.471.4 cm
(1.3–6.7 cm). There was no statistical difference between
patients whose diagnosis was made by TBBs or not (3.471.5
versus 3.371.2 cm) (P ¼ 0:899). Excluding 2 lesions which
were located at the lingula and were not diagnostic, the
diagnostic yields of lesions located in the remaining 5 lobes
were not statistically different (P ¼ 0:205). Additionally, the
diagnostic yield of TBBs was 87.5%, 85.0% and 66.7% inlesions43 cm, lesions42 cm but p3 cm and lesions p2 cm
in diameter, respectively. The difference was still not
statistically significant (P ¼ 0:218).
Factors influencing the diagnostic yield of EBUS-
guided TBB
Factors that influenced the diagnostic yield of EBUS-guided
TBB, diagnosis of malignancy (P ¼ 0:047), probe located
within the lesion on EBUS image (Po0:0001), and measured
distance before biopsy (P ¼ 0:004) were evident (Table 4).
We used multivariate logistic regression testing to take into
account the above three factors. Only the last two, probe
located within the lesion on EBUS image (P ¼ 0:001) and
measured distance before biopsy (P ¼ 0:002), were statisti-
cally significant.
Discussion
Kurimoto et al. assessed the ability of EBUS using a GS to
diagnose PPLs. One hundred and sixteen of 150 were
diagnostic (77%) from TBBs or bronchial brushing cytology.7
Another study was conducted of EBUS-GS-guided TBB
performed in 24 patients with 24 PPLs of less than 30mm
in diameter. Nineteen patients whose PPLs were visible on
EBUS images subsequently underwent an EBUS-GS-guided
diagnostic procedure. A total of 14 lesions (58.3%) were
diagnosed. Even when restricted to PPLs o20mm in
diameter, the diagnostic sensitivity was 53%.5 However,
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Table 3 Comparison between EBUS-D and EBUS groups.
Group EBUS-D Group EBUS P-value
Number of patients 57 56
Gender
Male 37 (64.9%) 38 (67.9%) 0.740
Female 20 (35.1%) 18 (32.1%)
Age (yr) 59.1713.9 (25–79) 59.7711.6 (20–77) 0.802
Size of lesions (mm) 23.978.3 (10–44) 25.278.2 (11–41) 0.402
Location of lesions
Right upper lobe 14 (24.6%) 16 (28.6%) 0.928
Right middle lobe 9 (15.8%) 6 (10.7%)
Right lower lobe 15 (26.3%) 12 (21.4%)
Left upper lobe 8 (14.0%) 9 (16.1%)
Lingula 2 (3.5%) 3 (5.4%)
Left lower lobe 9 (15.8%) 10 (17.9%)
Probe within the lesion 44 (77.2%) 42 (75.0%) 0.785
Time of EBUS (sec) 179.7731.8 (95–273) 176.0727.5 (65–216) 0.516
Number of specimens
3 22 (38.6%) 18 (32.1%) 0.611
4 12 (21.1%) 16 (28.6%)
5 23 (40.4%) 22 (39.3%)
Complication
Bleeding 3 (5.3%) 2 (3.6%) 0.549
Pneumothorax 0 (0%) 1 (1.8%)
Final diagnosis
Malignant 42 (73.7%) 40 (71.4%) 0.503
Benign 12 (21.1%) 15 (26.8%)
Lost to follow up 3 (5.3%) 1 (1.8%)
Diagnostic yield 45 (78.9%) 32 (57.1%) 0.013
EBUS for peripheral pulmonary lesions 743fluoroscopy was used to confirm whether the forceps
reached the lesion in the above two studies. Asahina et al.
performed TBB using EBUS-GS with virtual bronchoscopy
(VB) navigation for 29 patients with 30 small PPLs p30mm
in diameter. Nineteen lesions (63.3%) were diagnosed from
histopathologic or cytologic examination. Diagnostic sensi-
tivities were 44.4% for lesiono20mm in diameter and 91.7%
for lesions 20–30mm in diameter.10 The diagnostic yield of
EBUS-guided TBBs was 78.9% in group EBUS-D patients with
PPLs 23.978.3mm (10–44mm) in diameter. Surprisingly, the
diagnostic yield reached 66.7% even in PPLsp20mm. If your
hospital’s bronchoscopy unit is without GS, fluoroscopy, and
VB equipment, this is an alternative which produces
satisfactory results with regard to diagnostic yield.
Herth et al. conducted a prospective study of 50
consecutive patients referred for TBBs for PPLs who under-
went fluoroscopy- and EBUS-guided TBBs in random order.
Diagnostic yield was obtained in 80% of patients with EBUS
and 76% of patients with fluoroscopy.11 Achieving such
remarkable results not only requires careful study of
individual differences among patients, but also requires an
experienced and technically proficient bronchoscopist oper-
ating the EBUS-guided TBBs, as well as an outstandingpathologist to correctly interpret the specimens. The
diagnostic yield of TBBs performed on group-EBUS patients
in our study was only 57.1%, significantly lower than the
diagnostic yield of TBBs performed on group EBUS-D
patients. We believe the distance between the bronchial
orifice and the lesion plays an important role. With our
method, PPLs which were visible on EBUS images allowed
the probe to pass through them and were detected while the
probe was pulled back subsequently. Furthermore, the
transducer was positioned about 1 cm behind the tip of
probe. If the probe could not pass through the PPLs, the tip
of probe was against them so that the transducer could not
touch as well as detect them while the probe was
withdrawn. In the absence of fluoroscopy equipment, when
EBUS-guided TBBs were performed regardless of distance,
the biopsy forceps with closed cups or the GS might be
introduced beyond the PPLs which were visualized on EBUS.
Biopsies performed with an inappropriate distance may
result in decreased diagnostic yield.
Baaklini et al. investigated factors affecting the diag-
nostic yield of bronchoscopy in 177 patients with pulmonary
nodules. They found that when lesions were grouped
according to distance from the hilum on CT, yields of
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Table 4 Factors influencing the diagnostic yield of EBUS-guided TBB.
Positive diagnosis Negative diagnosis P-value
Number of patients 77 32
Gender
Male 54 (70.1%) 19 (59.4%) 0.277
Female 23 (29.9%) 13 (40.6%)
Age (years) 59.3713.2 (20–79) 58.5712.1 (26–77) 0.771
Size of lesions (mm) 25.477.7 (11–44) 23.079.4 (10–41) 0.162
Location of lesions
Right upper lobe 21 (27.3%) 9 (28.1%) 0.105
Right middle lobe 9 (11.7%) 3 (9.4%)
Right lower lobe 23 (29.9%) 4 (12.5%)
Left upper lobe 13 (16.9%) 4 (12.5%)
Lingula 2 (2.6%) 3 (9.4%)
Left lower lobe 9 (11.7%) 9 (28.1%)
Probe within the lesion 67 (87.0%) 17 (53.1%) o0.0001
Measured distance before biopsy 45 (58.4%) 9 (28.1%) 0.004
Duration of EBUS (sec) 180.0729.2 (114–273) 172.0732.2 (65–215) 0.208
Number of specimens
3 25 (32.5%) 13 (40.6%) 0.523
4 22 (28.6%) 6 (18.8%)
5 30 (39.0%) 13 (40.6%)
Final diagnosis
Malignant 62 (80.5%) 20 (62.5%) 0.047
Benign 15 (19.5%) 12 (37.5%)
EBUS-guided TBB: endobronchial ultrasonography-guided transbronchial biopsy.
Y.-H. Chung et al.744bronchoscopy in central, intermediate and peripherally
located lesions were 82%, 61% and 53%, respectively.12
Radke et al. reported 97 PPLs evaluated by fluoroscopy-
guided bronchoscopy. The diagnostic yield was similar for
lesions located in the outer and middle third of the lung;
inner one-third lesions were correctly diagnosed more
frequently.13 Generally, the diagnostic yield was lower when
the PPL was located more peripherally. However, in our
EBUS-D group, TBBs were performed according to appro-
priate distance. The mean measured distances were not
significantly different between patients whose lesions were
diagnosed or not.
Kikuchi et al.5 reported that in 13 of 14 cases in which the
probe was located within the lesion on EBUS image,
cytopathological diagnosis was obtained. Kurimoto et al.2
found that cases in which the probe was located within the
lesion had a significantly higher diagnostic yield (87%) of
EBUS-GS procedures than when the probe was located
adjacent to it (42%). Evaluating factors that influence the
diagnostic yield of EBUS-guided TBB, the probe advanced
within the lesion on EBUS image was an independent
variable. The result would support previous studies. We
suggest that when two types of probe location were
visualized in different bronchi, respectively, introducing
the biopsy forceps into the bronchus where the probe was
located within the lesion will increase the diagnostic yield.There are two limitations concerning this method of
EBUS-guided TBBs. First, measuring the distance and then
advancing the biopsy forceps to this distance were
performed while patients held their breath. That is a
difficult problem for elderly patients with neurologic or
respiratory dysfunction. Second, the biopsy forceps could be
introduced into the subsegmental bronchus and advanced to
an appropriate distance. However, beyond the subsegmental
bronchus, the forceps might be introduced into a bronchial
branch which was not established previously by EBUS.
Recently, a study reported that a fairly good diagnostic
yield can still be obtained by using EBUS-guided TBBs with
GS, where fluoroscopy is incapable of detecting solitary
pulmonary nodules.14 If the distance is taken into account,
can the diagnostic yield be improved even further? In the
future, we may design a GS with a distance mark on it. This
new instrument will not only be placed in the target
bronchus by EBUS, but also advanced and adjusted the
appropriate distance for subsequent TBBs.Conclusion
As an alternative to EBUS with a GS and fluoroscopy,
measuring and applying the distance between the orifice
ARTICLE IN PRESS
EBUS for peripheral pulmonary lesions 745of bronchus and the lesion could increase the diagnostic
yield of EBUS-guided TBBs for PPLs.
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